发明公开
EP0508435A3 Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse
失效
稳定化的药物组合物(LEU 13)-MOTILIN-HSE
- 专利标题: Pharmaceutical composition of stabilized [Leu 13]-motilin-Hse
- 专利标题(中): 稳定化的药物组合物(LEU 13)-MOTILIN-HSE
-
申请号: EP92106184.2申请日: 1992-04-09
-
公开(公告)号: EP0508435A3公开(公告)日: 1993-04-07
- 发明人: Sawai, Kiichi, c/o Sanwa Kagaku Kenkyusho Co., Ltd , Kurono, Masayasu, c/o Sanwa Kagaku Kenkyusho , Kondo, Yasuaki, c/o Sanwa Kagaku Kenkyusho Co. Ltd , Sato, Makoto, c/o Sanwa Kagaku Kenkyusho Co., Ltd. , Kouzaki, Toshiyuki, c/o Sanwa Kagaku Kenkyusho
- 申请人: SANWA KAGAKU KENKYUSHO CO., LTD.
- 申请人地址: No. 35, Higashi-sotobori-cho, Higashi-ku Nagoya, Aichi-ken JP
- 专利权人: SANWA KAGAKU KENKYUSHO CO., LTD.
- 当前专利权人: SANWA KAGAKU KENKYUSHO CO., LTD.
- 当前专利权人地址: No. 35, Higashi-sotobori-cho, Higashi-ku Nagoya, Aichi-ken JP
- 代理机构: Wächtershäuser, Günter, Prof. Dr.
- 优先权: JP76202/91 19910409; JP87484/92 19920312
- 主分类号: A61K38/22
- IPC分类号: A61K38/22 ; A61K47/06 ; A61K47/42
摘要:
There is disclosed a pharmaceutical composition of stabilized [Leu¹³]-motilin-Hse. The composition comprises at least one of organic acids and salts thereof, as a first stabilizer, and pH thereof is adjusted in a range of 5.5 - 8.0. The composition may contain at least one of substances selected from saccharides, amino acids, proteins and salts thereof, as a second stabilizer. Conversion of [Leu¹³]-motilin-Hse into [Leu¹³]-motilin-Hse-lactone is suppressed by increasing pH value and deamidization in asparagine residue at 19-position is suppressed by the presence of the organic acid or salt thereof.
公开/授权文献
信息查询
IPC分类: